Skip to main content
Advertisement

Main menu

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Special Sections
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET

User menu

  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Molecular Pharmacology
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET
  • My alerts
  • Log in
  • My Cart

Molecular Pharmacology

Advanced Search

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Special Sections
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Visit molpharm on Facebook
  • Follow molpharm on Twitter
  • Follow molpharm on LinkedIn

Molecular Pharmacology is excited to WELCOME a new Editor-in-Chief

ASPET Ends Page Charges for Open Access Articles

Molecular Pharmacology is excited to WELCOME six new Editorial Advisory Board members.

Call for Papers - Special Section on Sphingolipids for January 2024

  • Victor Jun Yu Lim
  • Upacicalcet Binds to the Amino Acid Binding Site of CaSR
  • Extrachromosomal circular DNAs and CRISPR-Cas9 System
  • α-Conotoxin Binding Site on the GABAB Receptor
  • Upacicalcet Binds to the Amino Acid Binding Site of CaSR
  • 1
  • 2
  • 3
  • 4
  • 5

Latest Fast Forward Articles

  • You have access
    Aryl hydrocarbon receptor as a therapeutical target of environmentally induced skin conditions
    Caroline de Almeida Freitas Accioli, Michelle Sabrina da Silva, Bianca Aloise Maneira Corrêa Santos and Carlos Rangel Rodrigues
    Molecular Pharmacology February 2, 2023, MOLPHARM-MR-2022-000627; DOI: https://doi.org/10.1124/molpharm.122.000627
  • You have access
    The Small Molecule Antagonist KCI807 Disrupts Association of the Amino-terminal Domain of the Androgen Receptor with ELK1 by Modulating the Adjacent DNA Binding Domain
    Claire Soave, Charles Ducker, Naeyma Islam, Seongho Kim, Sally Yurgelevic, Nathan I Nicely, Luke Pardy, Yanfang Huang, Peter Shaw, Gregory Auner, Alex Dickson and Manohar Ratnam
    Molecular Pharmacology January 31, 2023, MOLPHARM-AR-2022-000589; DOI: https://doi.org/10.1124/molpharm.122.000589
  • You have access
    Genetic Knockout of Fatty Acid Amide Hydrolase (FAAH) Ameliorates Cisplatin-induced Nephropathy in Mice
    Chaoling Chen, Weili Wang, Marissa Raymond, Fereshteh Ahmadinejad, Justin Poklis, Brandon Em, David A. Gewirtz, Aron H. Lichtman and Ningjun Li
    Molecular Pharmacology January 26, 2023, MOLPHARM-AR-2022-000618; DOI: https://doi.org/10.1124/molpharm.122.000618
  • You have access
    CRISPR/Cas9-mediated induction of relapse-specific NT5C2 and PRPS1 mutations confers thiopurine resistance as a relapsed lymphoid leukemia model
    Thao Thu Thi Nguyen, Yoichi Tanaka, Masashi Sanada, Masumi Hosaka, Minori Tamai, Keiko Kagami, Chiaki Komatsu, Shinpei Somazu, Daisuke Harama, Shin Kasai, Atsushi Watanabe, Koushi Akahane, Kumiko Goi and Takeshi Inukai
    Molecular Pharmacology January 20, 2023, MOLPHARM-AR-2022-000546; DOI: https://doi.org/10.1124/molpharm.122.000546
  • You have access
    A novel role of uricosuric agent benzbromarone in BK channel activation and reduction of airway smooth muscle contraction
    Jian Gao, Hao Yin, Yanqun Dong, Xintong Wang, Yani Liu and KeWei Wang
    Molecular Pharmacology January 20, 2023, MOLPHARM-AR-2022-000638; DOI: https://doi.org/10.1124/molpharm.122.000638
  • You have access
    Use-dependent relief of inhibition of Nav1.8 channels by A-887826
    Sooyeon Jo, Han-Xiong Bear Zhang and Bruce P. Bean
    Molecular Pharmacology January 12, 2023, MOLPHARM-AR-2022-000593; DOI: https://doi.org/10.1124/molpharm.122.000593
View more published ahead of print articles

About Molecular Pharmacology

Molecular Pharmacology publishes findings derived from the application of innovative structural biology, biochemistry, biophysics, physiology, genetics, and molecular biology to basic pharmacological problems that provide mechanistic insights that are broadly important for the fields of pharmacology and toxicology. Relevant topics include:

  • Molecular Signaling / Mechanism of Drug Action
  • Chemical Biology / Drug Discovery
  • Structure of Drug-Receptor Complex
  • Systems Analysis of Drug Action
  • Drug Transport / Metabolism

Current issue

Molecular Pharmacology: 103 (2)
Molecular Pharmacology
Vol. 103, Issue 2
1 Feb 2023
  • Table of Contents
  • Table of Contents (PDF)
  • About the Cover
  • Index by author
  • Editorial Board (PDF)
  • Front Matter (PDF)

Molecular Pharmacology is published continuously. New articles are added as they become ready and assigned to monthly issues. Check this site for new content or sign up for content alerts.

EDITOR'S CHOICE ARTICLES FOR FEBRUARY 2023:

  • A Complete Endocannabinoid Signaling System Modulates Synaptic Transmission between Human Induced Pluripotent Stem Cell–Derived Neurons
  • Most Cited
  • Most Read
Loading
  • SB-431542 Is a Potent and Specific Inhibitor of Transforming Growth Factor-β Superfamily Type I Activin Receptor-Like Kinase (ALK) Receptors ALK4, ALK5, and ALK7
  • The G-Protein-Coupled Receptors in the Human Genome Form Five Main Families. Phylogenetic Analysis, Paralogon Groups, and Fingerprints
  • Pharmacological Properties of Y-27632, a Specific Inhibitor of Rho-Associated Kinases
  • Pharmacological characterization of five cloned voltage-gated K+ channels, types Kv1.1, 1.2, 1.3, 1.5, and 3.1, stably expressed in mammalian cell lines.
  • The Orphan Human Pregnane X Receptor Mediates the Transcriptional Activation of CYP3A4 by Rifampicin through a Distal Enhancer Module
More...
Advertisement
For an alternate route to this Journal use this URL: http://intl-molpharm.aspetjournals.org
Back to top
  • Home
  • Alerts
Facebook   Twitter   LinkedIn   RSS

Navigate

  • Current Issue
  • Fast Forward by date
  • Fast Forward by section
  • Latest Articles
  • Archive
  • Search for Articles
  • Feedback
  • ASPET

More Information

  • About Molecular Pharmacology
  • Editorial Board
  • Instructions to Authors
  • Submit a Manuscript
  • Customized Alerts
  • RSS Feeds
  • Subscriptions
  • Permissions
  • Terms & Conditions of Use

ASPET's Other Journals

  • Drug Metabolism and Disposition
  • Journal of Pharmacology and Experimental Therapeutics
  • Pharmacological Reviews
  • Pharmacology Research & Perspectives
ISSN 1521-0111 (Online)

Copyright © 2023 by the American Society for Pharmacology and Experimental Therapeutics